The shareholders of AGILOX Systems GmbH rely on the comprehensive legal expertise of DORDA in the transaction with The Carlyle Group.
Vienna, 22 June 2021 – AGILOX, based in Neukirchen bei Lambach (Upper Austria), with its AI-based and self-driving logistics robots, is the subject of an investment by The Carlyle Group, one of the world's largest private equity firms based in Washington, D.C.
The shareholders of AGILOX were supported in this transaction, that was signed on 18 June 2021, by DORDA experts led by Corporate/M&A Partners Martin Brodey and Bernhard Rieder. Specifically, the advice related the sale of parts of the company shares held by the company's founders as well as the investors of the last financing round consisting of two fund companies of the Raiffeisen Invest Private Equity Group.
The comprehensive advice involved experts from various DORDA teams: Mike Schaunig (Associate, M&A, Corporate), Clemens Semelmayer (Associate, M&A, Corporate), Katharina Binder (Associate, Private Client, Tax), Patricia Backhausen (Attorney at Law, M&A, Corporate), Paul Doralt (Partner, Private Client, Tax), Alexandra Ciarnau (Attorney at Law , Data Protection, IT/IP), Christian Ritschka (Partner, M&A, Corporate), Elisabeth König (Of Counsel, Competition & Antitrust), Bernhard Heinzl (Attorney at Law, IT/IP), Nino Tlapak (Partner, Data Protection, IT/IP), Julia Sophie Haumer-Mörzinger (Attorney at Law, Real Estate and Construction), Edith Ludwig (Attorney at Law, Tax), Lisa Todeschini (Associate, Competition & Antitrust), Heinrich Kühnert (Partner, Competition & Antitrust) and Andreas Seling (Attorney at Law, IT/IP).
Martin Brodey: "This transaction will further accelerate AGILOX's growth. Especially in the fast growing AMR market, the investment of Carlyle and its global network is very important for the further development of AGILOX. We are very pleased that we were able to successfully contribute our know-how to this highly specialized project. I would like to thank our entire team for their great efforts."
The transaction is subject to regulatory approval. Details of the transaction are to be kept confidential.